iRhythm Technologies Inc (LTS:0A7L)
$ 90.2 3.795 (4.39%) Market Cap: 2.81 Bil Enterprise Value: 3.03 Bil PE Ratio: 0 PB Ratio: 39.20 GF Score: 72/100

iRhythm Technologies Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 07:50PM GMT
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Welcome, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan, and I'm very happy to introduce our next company, which is iRhythm. And today is a first, its new CEO, Mike Coyle's first day at work, first day at the JPMorgan conference and first time presenting as the CEO.

But before I hand it over to Mike, I just want to make a few housekeeping announcements. You can go ahead and get the slide deck from the JPMorgan conference website. You can go there to submit a question. I'll do my best to add -- to ask Mike all of the questions in the breakout afterwards, or feel free to e-mail me or chat me on Bloomberg.

So with all that out of the way, Mike, why don't you go ahead, and we'll join you afterwards for Q&A.

Michael J. Coyle
iRhythm Technologies, Inc. - President, CEO & Director

Thank you very much, Robbie. And as Robbie just mentioned, this is my first day on the job. I couldn't think of a better place to start it than at the JPMorgan conference.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot